How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study. [electronic resource]
Producer: 20101020Description: 308-14 p. digitalISSN:- 1744-9987
- Adult
- Aged
- Antimicrobial Cationic Peptides -- blood
- C-Reactive Protein -- metabolism
- Case-Control Studies
- Female
- Hepcidins
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Interleukin-6 -- blood
- Kidney Failure, Chronic -- therapy
- Male
- Middle Aged
- Protein Precursors -- blood
- Renal Dialysis
- Simvastatin -- pharmacology
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.